WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Germany and Real Madrid great Toni Kroos to retire after Euro 2024
Britney Spears' sister Jamie Lynn Spears isn't bothered by Toxic singer branding her a 'b***h
Israel has briefed US on plan to evacuate Palestinian civilians ahead of potential Rafah operation
Machete attack victim, 19, 'murdered by two 12
Vegas use of injured reserve prompts questions about salary cap. Other NHL teams do same thing
Sudan: UN warns that Darfur risks starvation and death if aid isn't allowed in
Britney Spears breaks silence after 'huge bust
'IF' movie review: John Krasinski’s film hits a box office nerve with $35 million debut
Ireland knocks out Argentina again in Singapore Sevens
Adela Cernousek of Texas A&M wins NCAA individual golf title for first collegiate win
Nicki Minaj surprises Barbz as she brings out Cyndi Lauper to perform Pink Friday Girls in Brooklyn